title: Can morbidity and mortality of matched allogeneic marrow grafts be reduced?
authors.affiliation: Department of Haematology, St Vincent's Hospital, Sydney, Australia.
authors.forename: J C
authors.initials: JC
authors.lastname: Biggs
authors.forename: K
authors.initials: K
authors.lastname: Atkinson
authors.forename: A J
authors.initials: AJ
authors.lastname: Dodds
authors.forename: K
authors.initials: K
authors.lastname: Downs
mesh_terms: D000206:Actuarial Analysis; D016026:Bone Marrow Transplantation; D003556:Cystitis / Q000517:prevention & control; D006504:Hepatic Veno-Occlusive Disease / Q000401:mortality / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011183:Postoperative Complications / Q000401:mortality / Q000517:prevention & control*; D011300:Preoperative Care; D011658:Pulmonary Fibrosis / Q000401:mortality / Q000517:prevention & control; D014184:Transplantation, Homologous / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents